This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009 Feb 19;360(8):790-800.

doi: 10.1056/NEJMra0801289.

Gene-expression signatures in breast cancer

Christos Sotiriou¹, Lajos Pusztai

Affiliations

PMID: 19228622
DOI: 10.1056/NEJMra0801289

Review

Gene-expression signatures in breast cancer

Christos Sotiriou et al. N Engl J Med. 2009.

. 2009 Feb 19;360(8):790-800.

doi: 10.1056/NEJMra0801289.

Authors

Christos Sotiriou¹, Lajos Pusztai

Affiliation

¹ Medical Oncology Department, Translational Research Unit, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. [email protected]

PMID: 19228622
DOI: 10.1056/NEJMra0801289

No abstract available

PubMed Disclaimer

Similar articles

[Molecular phenotypes of breast cancer and their clinical application].
Tang P, Wei B, Hicks DG, Skinner K, Bu H. Tang P, et al. Zhonghua Bing Li Xue Za Zhi. 2009 Jan;38(1):13-7. Zhonghua Bing Li Xue Za Zhi. 2009. PMID: 19489219 Chinese. No abstract available.
Prediction of cancer outcome with microarrays.
Goldhirsch A, Gelber RD, Viale G, Colleoni M, Coates AS. Goldhirsch A, et al. Lancet. 2005 May 14-20;365(9472):1685-6; author reply 1686. doi: 10.1016/S0140-6736(05)66542-7. Lancet. 2005. PMID: 15894095 No abstract available.
Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F, Reis-Filho JS. Correa Geyer F, et al. Int J Surg Pathol. 2009 Aug;17(4):285-302. doi: 10.1177/1066896908328577. Epub 2008 Dec 22. Int J Surg Pathol. 2009. PMID: 19103611 Review.
High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy.
Naoi Y, Kishi K, Tanei T, Tsunashima R, Tominaga N, Baba Y, Kim SJ, Taguchi T, Tamaki Y, Noguchi S. Naoi Y, et al. Cancer. 2011 Feb 1;117(3):472-9. doi: 10.1002/cncr.25626. Epub 2010 Sep 27. Cancer. 2011. PMID: 20878674
Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
Huber KE, Carey LA, Wazer DE. Huber KE, et al. Semin Radiat Oncol. 2009 Oct;19(4):204-10. doi: 10.1016/j.semradonc.2009.05.004. Semin Radiat Oncol. 2009. PMID: 19732684 Review.

See all similar articles

Cited by

A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.
Rafiq S, Khan S, Tapper W, Collins A, Upstill-Goddard R, Gerty S, Blomqvist C, Aittomäki K, Couch FJ, Liu J, Nevanlinna H, Eccles D. Rafiq S, et al. PLoS One. 2014 Dec 19;9(12):e101488. doi: 10.1371/journal.pone.0101488. eCollection 2014. PLoS One. 2014. PMID: 25526632 Free PMC article.
Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.
Banys-Paluchowski M, Schneck H, Blassl C, Schultz S, Meier-Stiegen F, Niederacher D, Krawczyk N, Ruckhaeberle E, Fehm T, Neubauer H. Banys-Paluchowski M, et al. Geburtshilfe Frauenheilkd. 2015 Mar;75(3):232-237. doi: 10.1055/s-0035-1545788. Geburtshilfe Frauenheilkd. 2015. PMID: 25914415 Free PMC article.
Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis.
Tang H, Sebti S, Titone R, Zhou Y, Isidoro C, Ross TS, Hibshoosh H, Xiao G, Packer M, Xie Y, Levine B. Tang H, et al. EBioMedicine. 2015 Mar;2(3):255-263. doi: 10.1016/j.ebiom.2015.01.008. EBioMedicine. 2015. PMID: 25825707 Free PMC article.
Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial).
Iwamoto T, Niikura N, Watanabe K, Takeshita T, Kikawa Y, Kobayashi K, Iwakuma N, Okamura T, Kobayashi T, Katagiri Y, Kitada M, Tomioka N, Miyoshi Y, Shigematsu H, Miyashita M, Ishiguro H, Masuda N, Saji S. Iwamoto T, et al. Breast Cancer Res Treat. 2024 Nov;208(2):253-262. doi: 10.1007/s10549-024-07414-7. Epub 2024 Jun 26. Breast Cancer Res Treat. 2024. PMID: 38922548
Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries.
Zhu W, Perez EA, Hong R, Li Q, Xu B. Zhu W, et al. PLoS One. 2015 May 28;10(5):e0128345. doi: 10.1371/journal.pone.0128345. eCollection 2015. PLoS One. 2015. PMID: 26020519 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information